Skip to main content

Table 2 Some diseases and therapeutics involving both miRNA and eRNA

From: Enhancer RNAs: transcriptional regulators and workmates of NamiRNAs in myogenesis

Diseases and therapeutics miRNA eRNA
General cell signaling pathway miRNAs [75] NET1e [87]
MAP kinases and NFkB miR-22 and miR-140 [91] ADAMDEC1 eRNA[22]
Adenocarcinoma miR-3131, miR-664, miR-483 and miR-150 [92] NET1e, general eRNAs [87]
Cancer miR-375[93], miR-137 [94] eRNAs of BRCA [87]
Prostate cancer miR-373 [51] KLK3e [10]
Tumor suppression miR-17-92 [89] p53BERs eRNAs [11]
Apoptosis and tumorigenesis miR-129-2 [95], miR-495 [96], microRNA-378 [97] lnc-SLC4A1-1 [98] general eRNAs[99]
Immunity miR-212 [100] AP001056.1 [101]
Breast cancer miR-200b ~ 200a ~ 429 [90] miR-200b eRNA [90], NET1e [87] estrogen receptor α (ER-α)-bound eRNA( +) [102]
Drug resistance miR-17 [86] NET1e [87]